J.P. Morgan Healthcare Equity Securities Investment Fund (abbreviation: J.P. Morgan Healthcare Equity C, code 014932) announced its latest net value on April 10, up 3.00%.
J.P. Morgan Healthcare Stock C was established on January 25, 2022, and the performance comparison benchmark is the return rate of Shenyin Wanguo Pharmaceutical and Biological Industry Index ×85% + the return rate of China Bond Total Index ×15%. The fund has returned -38.89% since its inception, 9.86% this year, 2.62% over the past month, 7.98% over the past year, and -29.62% over the past three years. In the past year, the fund ranked 1796/3503 in its peer group.
The fund manager is Ye Min. Ye Min has managed (or intends to manage) the fund since March 29, 2024, with a return of 4.99% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600276 | Hengrui Pharmaceutical | 9.15% | 990974 | 45.4857 million |
| 002422 | Kelun Pharmaceutical | 7.19% | 1193999 | 35.7364 million |
| 688578 | Allist | , 6.73% | 558288 | 33.4415 million |
| 688506 | Baili Tianheng | 6.63%, | 171917 | 32.9616 million |
| 603259 | WuXi AppTec | 5.61% | 506700 | 27.8888 million |
| 688617 | Huitai Medical | 5.47% | 72994 | 27.1779 million |
| 688235 | BeiGene 5.20% | 160526 | 25.8479 million | |
| 688076 | Nuotai Biotech | 4.78% | 457482 | 23.7525 million |
| 688050 | Aibo Medical | 4.50% | 245577 | 22.3549 million |
| 300760 | Mindray Medical | 4.33% | 84388 | 21.5189 million |
Ticker Name
Percentage Change
Inclusion Date
